Cathie Wood, of ARK Genomic Revolution ETF(NYSE: ARKG) explains the multi-trillion dollar opportunity in the Genomics Revolution: CAR-T, CRISPR, and DNA Sequencing
The $TRILLION Opportunity in CRISPR & DNA Sequencing Technologies
Healthcare
CytoDyn (OTC: CYDY) Reaches Historical Milestone, Submits First of Three Sections of BLA to FDA for Leronlimab (PRO 140) as a Combination Therapy for HIV
FDA Previously Granted Rolling Review for BLA VANCOUVER, Washington, Mar 18, 2019 – CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”) a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential […]
Economy
“Calibrating Risks…But Markets Still Healthy” Howard Marks
Oaktree Capital Management’s, Howard Marks has a great sense of market timing. Marks says credit markets are getting more aggressive, but nowhere near excesses of 2007. Overall market’s remain healthy – “not purely good or […]
Smart Money
Dr. Mark Skousen prescribes “SWAN” for profits in 2019
Mark Skousen, Ph.D., editor of the legendary Forecasts and Strategies newsletter, discusses his outlook for stocks and the economy in 2019. Considered as one of the top economists, Mark is a highly pragmatic investor, who […]